Home > Quotes > BMY

Bristol-Myers Squibb Company Stock Quote & Summary Data

Get BMY Alerts
*Delayed - data as of Jan. 26, 2015 11:05 ET  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BMY Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
1 Year Target 60
Today's High /Low  / 
Share Volume
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 6,763,209
Previous Close $ 62.07
52 Week High/Low $ 64.44 / $ 46.30
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 103,623,767,393
P/E Ratio 38.33
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 34.68
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 1.63
Annualized dividend $ 1.48
Ex Dividend Date Dec. 30, 2014
Dividend Payment Date Feb. 2, 2015
Current Yield 2.38 %
Beta 0.87

Intraday Chart

ETFs with BMY as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
6.19% iShares Dow Jones US Pharmaceuticals Index Fund (IHE) +19.87  (14.44%)
4.74% PowerShares Dynamic Pharmaceuticals Portfolio (PJP) +7.45  (11.79%)
4.62% Market Vectors Pharmaceutical ETF (PPH) +4.21  (6.77%)
3.47% SPDR Health Care Select Sector Fund (XLV) +7.08  (11.09%)
3.24% iShares Dow Jones US Healthcare Sector Index Fund (IYH) +15.34  (11.40%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Bristol-Myers Squibb Company (which may be referred to as Bristol-Myers Squibb, BMS, the Company, we, our or us) was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. We are engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. We operate in one segment—BioPharmaceuticals. For additional information about business segments, see “Item 8. Financial Statements—Note 2. Business Segment Information.” We compete with other worldwide research-based drug companies, smaller research companies and generic drug manufacturers. Our products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession.  ... More ...  

Risk Grade

Where does BMY fit in the risk graph?

News for BMY

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?